白云山:关于子公司收购浙江省医药工业有限公司100%股权的进展公告

证券日报
Mar 03

  证券日报网讯 3月3日,白云山发布公告称,公司下属控股子公司广州医药与海正药业签署了《浙江省医药工业有限公司股权交易合同》,通过公开摘牌方式受让海正药业所持浙江省医药工业有限公司100%股权,转让价款为人民币50,050.00万元。截至本公告日,广州医药已按照《股权交易合同》的约定向海正药业支付了全部股权转让款。浙江医工已完成上述事项工商变更登记手续,本次目标公司股权已完成交割过户,广州医药持有浙江医工100%股权,浙江医工纳入广州医药合并财务报表范围。至此,本次股权交易事宜已全部完成。

(文章来源:证券日报)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10